BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 19577278)

  • 21. Biologic markers in endometrial cancer treatment.
    Engelsen IB; Akslen LA; Salvesen HB
    APMIS; 2009 Oct; 117(10):693-707. PubMed ID: 19775337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sparing fertility in young patients with endometrial cancer.
    Chiva L; Lapuente F; González-Cortijo L; Carballo N; García JF; Rojo A; Gonzalez-Martín A
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S101-4. PubMed ID: 18804267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An unusual presentation of endometrial cancer: a case report and literature review.
    Olawaiye A; Withiam-Leitch M; Prabhakar H; Goodman A
    Arch Gynecol Obstet; 2008 Aug; 278(2):103-6. PubMed ID: 18335228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial hyperplasia and the risk of progression to carcinoma.
    Lacey JV; Chia VM
    Maturitas; 2009 May; 63(1):39-44. PubMed ID: 19285814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship.
    Fader AN; Arriba LN; Frasure HE; von Gruenigen VE
    Gynecol Oncol; 2009 Jul; 114(1):121-7. PubMed ID: 19406460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of fecal biomarkers in inflammatory bowel disease.
    Sutherland AD; Gearry RB; Frizelle FA
    Dis Colon Rectum; 2008 Aug; 51(8):1283-91. PubMed ID: 18543035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma calprotectin concentrations in women with endometrial carcinoma.
    Ni Bhriain H; Trovik J; Wik E; Stefansson IM; Akslen LA; Salvesen HB; Staff AC
    Gynecol Oncol; 2009 Sep; 114(3):491-5. PubMed ID: 19577278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of calprotectin in obstetrics and gynecology.
    Kostakis ID; Cholidou KG; Kallianidis K; Perrea D; Antsaklis A
    Eur J Obstet Gynecol Reprod Biol; 2010 Jul; 151(1):3-9. PubMed ID: 20378239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
    Gisbert JP; McNicholl AG
    Dig Liver Dis; 2009 Jan; 41(1):56-66. PubMed ID: 18602356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of early-stage endometrial cancer.
    Lu KH
    Semin Oncol; 2009 Apr; 36(2):137-44. PubMed ID: 19332248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancer.
    Zivanovic O; Carter J; Kauff ND; Barakat RR
    Gynecol Oncol; 2009 Dec; 115(3):504-9. PubMed ID: 19758691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Measurement of calprotectin in faeces].
    Jahnsen J; Røseth AG; Aadland E
    Tidsskr Nor Laegeforen; 2009 Apr; 129(8):743-5. PubMed ID: 19373299
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.